Keith Gray used his labs to operate a cardiovascular genetic testing fraud scheme, resulting in Medicare paying $54 million in false claims.
FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results